Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Rochelle P. Walensky, M.D.

Co-Author

This page shows the publications co-authored by Rochelle Walensky and Kenneth Mayer.
Connection Strength

1.154
  1. Call to action: how can the US Ending the HIV Epidemic initiative succeed? Lancet. 2021 03 20; 397(10279):1151-1156.
    View in: PubMed
    Score: 0.237
  2. Clinical Benefits and Cost-Effectiveness of Laboratory Monitoring Strategies to Guide Antiretroviral Treatment Switching in India. AIDS Res Hum Retroviruses. 2018 06; 34(6):486-497.
    View in: PubMed
    Score: 0.195
  3. Cost-effectiveness of HIV treatment as prevention in serodiscordant couples. N Engl J Med. 2013 Oct 31; 369(18):1715-25.
    View in: PubMed
    Score: 0.143
  4. The cost-effectiveness of tuberculosis preventive therapy for HIV-infected individuals in southern India: a trial-based analysis. PLoS One. 2012; 7(4):e36001.
    View in: PubMed
    Score: 0.128
  5. The cost-effectiveness of pre-exposure prophylaxis for HIV infection in South African women. Clin Infect Dis. 2012 May; 54(10):1504-13.
    View in: PubMed
    Score: 0.128
  6. Clinical impact and cost-effectiveness of antiretroviral therapy in India: starting criteria and second-line therapy. AIDS. 2007 Jul; 21 Suppl 4:S117-28.
    View in: PubMed
    Score: 0.092
  7. The Cost-effectiveness of Human Immunodeficiency Virus (HIV) Preexposure Prophylaxis and HIV Testing Strategies in High-risk Groups in India. Clin Infect Dis. 2020 02 03; 70(4):633-642.
    View in: PubMed
    Score: 0.055
  8. The cost-effectiveness and budgetary impact of a dolutegravir-based regimen as first-line treatment of HIV infection in India. J Int AIDS Soc. 2018 03; 21(3):e25085.
    View in: PubMed
    Score: 0.048
  9. HIV prevention in clinical care settings: 2014 recommendations of the International Antiviral Society-USA Panel. JAMA. 2014 Jul 23-30; 312(4):390-409.
    View in: PubMed
    Score: 0.037
  10. Clinical impact and cost-effectiveness of expanded voluntary HIV testing in India. PLoS One. 2013; 8(5):e64604.
    View in: PubMed
    Score: 0.035
  11. Cost-effectiveness of HIV testing referral strategies among tuberculosis patients in India. PLoS One. 2010 Sep 16; 5(9).
    View in: PubMed
    Score: 0.029
  12. Cost-effectiveness of tenofovir as first-line antiretroviral therapy in India. Clin Infect Dis. 2010 Feb 01; 50(3):416-25.
    View in: PubMed
    Score: 0.028
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.